all report title image

NEEDLE-FREE INJECTION SYSTEM MARKET ANALYSIS

Needle-free Injection System Market, by Product Type (Prefilled and Fillable), by Delivery Site (Subcutaneous Injectors, Intramuscular Injectors, and Intradermal Injectors), by Product Lifecycle (Disposable and Reusable), by Technology (Jet-based needle free injector, Spring-based needle free injector, and Laser-powered needle free injector), by Application (Vaccine and Other Biologic Product Delivery, Insulin Delivery, and Others), by End User (Hospitals & Clinics and Home Based Care), and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

  • To Be Published : Nov 2024
  • Code : CMI1681
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

Needle-Free Injection System MarketSize and Trends

Market Dynamics

Needle-free injection system is continuously expanding its market footprint on account of various factors. Increasing incidence of needle associated injuries and needle phobia amongst children and adults is expected to drive growth of needle-free injection system market. According to a study published in Behavioral Neurology, 2014, around 3-4 % of the world population faces needle phobia. This impacts their hospital or clinic visits, as they avoid visiting such facilities due to fear of exposure to needles. Needle phobia also impacts the vaccination amongst children, as most of them perceives injecting vaccine as a painful procedure. According to a study published in the Clinical Journal of Pain in 2015, there were 12 billion vaccination every year worldwide, most of which required injecting drug with a needle syringe system. Increasing demand for vaccines and other biologic products is another factor boosting growth of the needle-free injection system market. According to the World Health Organization (WHO) 2018, globally around 86% of infants are vaccinated against 26 diseases, however, 19.5 million children are unvaccinated leading to death of 2-3 million children every year. Chronic disease such as diabetes often needs daily dose of insulin, which has to be administered through pain needles. This may lead to lack of adherence to treatment due to lack of confidence to self-inject insulin. Increasing research on biologics and biosimilar is another factor expected to fuel growth of the market. Biologicals are increasingly launched and prescribed to treat disease such as GI tract disease (ulcerative colitis and Crohn’s disease), central nervous system associated disease (multiple sclerosis and Alzheimer’s disease), and cancer. Other factors such as increasing incidence of communicable diseases caused due to conventional needle, increasing geriatric population worldwide who need palliative care, and growing awareness about safe injection practices are also expected to drive growth of needle-free injection system market.

Market Taxonomy

On the basis of product type:

  • Prefilled
  • Fillable

On the basis of delivery site:

  • Subcutaneous Injectors
  • Intramuscular Injectors
  • Intradermal Injectors

On the basis of product lifecycle:

  • Disposable
  • Reusable

On the basis of technology:

  • Jet-based needle free injector
  • Spring-based needle free injector
  • Laser-powered needle free injector

On the basis of application:

  • Vaccine and other biologic product delivery
  • Insulin Delivery
  • Others

On the basis of end user:

  • Hospitals & Clinics
  • Home based care

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.